Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) EBITDA Margin (2020 - 2025)

PROCEPT BioRobotics has reported EBITDA Margin over the past 6 years, most recently at 39.08% for Q4 2025.

  • Quarterly results put EBITDA Margin at 39.08% for Q4 2025, down 1164.0% from a year ago — trailing twelve months through Dec 2025 was 31.05% (up 966.0% YoY), and the annual figure for FY2025 was 31.05%, up 966.0%.
  • EBITDA Margin for Q4 2025 was 39.08% at PROCEPT BioRobotics, down from 25.47% in the prior quarter.
  • Over the last five years, EBITDA Margin for PRCT hit a ceiling of 25.19% in Q2 2025 and a floor of 181.11% in Q4 2021.
  • Median EBITDA Margin over the past 5 years was 73.29% (2023), compared with a mean of 89.05%.
  • Biggest five-year swings in EBITDA Margin: surged 40794bps in 2021 and later crashed -1164bps in 2025.
  • PROCEPT BioRobotics' EBITDA Margin stood at 181.11% in 2021, then soared by 34bps to 119.42% in 2022, then soared by 47bps to 62.9% in 2023, then skyrocketed by 56bps to 27.44% in 2024, then plummeted by -42bps to 39.08% in 2025.
  • The last three reported values for EBITDA Margin were 39.08% (Q4 2025), 25.47% (Q3 2025), and 25.19% (Q2 2025) per Business Quant data.